Wilson Martin sold 631 shares of ROCKET PHARMACEUTICALS, INC. at $3.38 for −$2.13k on Aug 18, 2026

Sell
Form 4 code S. Open-market or private sale of a non-derivative or derivative security.
General Counsel
General Counsel
Filed Aug 20, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
−$2,133.41Shares × reported price
Shares traded
631Common Stock
Price per share
$3.38Reported price. Read footnotes for ranges.
% of reported position traded
0.09%This security and ownership context
Holdings after
673,853Direct
Trade date
Aug 18, 2026Sell
Filed
Aug 20, 2026, 5:30 PM ET2-day reporting delay
Accession
0001140361-26-033915Code S · Transaction 13351
How reported position traded is calculated

Shares sold ÷ (holdings after + shares sold). Estimated position before: 674,484 shares.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

RCKT price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
RCKT · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago −0.9%1w ago +0.9%1d ago −2%
Returns since7d +4.3%30d −2.9%90d180d1y

Footnotes in full

F1: Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. F2: The shares of common stock were sold by the Reporting Person in order to pay tax withholding obligations in connection with the vesting of RSUs.